Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Active Not Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0088318 (Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02775812Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell CarcinomaTreatment